Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes: A 24-week, randomized, double-blind, placebo-controlled trial

por Häring, Hans-Ulrich, Merker, Ludwig, Seewaldt-Becker, Elke, Weimer, Marc, Meinicke, Thomas, Woerle, Hans J., Broedl, Uli C.
Publicado 2013